Ph1 study of FIH of ABBV-291 in Non-Hodgkin's Lymphoma
Phase I Clinical Trial
A Phase 1 First-In-Human Study Evaluating Safety Pharmacokinetics and Efficacy of ABBV-291 in Non-Hodgkin's Lymphoma (M24-893)
Participating Locations
A Phase 1 First-In-Human Study Evaluating Safety Pharmacokinetics and Efficacy of ABBV-291 in Non-Hodgkin's Lymphoma (M24-893)